Dana-farber Cancer Institute Blog Years of Research Help Forge a New Path in Hodgkin Lymphoma Treatment

Medical advances tend to unfold slowly over many years, fueled by successive clinical studies that build upon each other and together provide the evidence needed to change patient care. A key illustration of this point comes from a recent phase 3 clinical trial, published last October in the New England Journal of Medicine (NEJM), which ... Read moreThe post Years of Research Help Forge a New Path in Hodgkin Lymphoma Treatment appeared first on Dana-Farber Cancer Institute.